Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$186.65 USD
+0.36 (0.19%)
Updated Dec 26, 2024 04:00 PM ET
After-Market: $186.53 -0.12 (-0.06%) 6:20 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Price, Consensus and EPS Surprise
CRL 186.65 +0.36(0.19%)
Will CRL be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for CRL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRL
Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?
CRL Stock to Gain From the Global Biotech Incubator Program Launch
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is it the Right Time to Hold Charles River Stock in Your Portfolio?
Charles River (CRL) International Revenue in Focus: Trends and Expectations
Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall
Other News for CRL
Fortrea: Turning Around As The Activists Move In
Interesting CRL Put And Call Options For August 2025
Early notable gainers among liquid option names on December 17th
Early notable gainers among liquid option names on December 17th
Tracking John Rogers' Ariel Investments Portfolio - Q3 2024 Update